Suppr超能文献

Shortening the infusion time of anticancer drugs: who will benefit?

作者信息

Margolin Kim, Gordon Michael

出版信息

J Clin Oncol. 2007 Jul 1;25(19):2642-3. doi: 10.1200/JCO.2007.10.7334.

Abstract
摘要

相似文献

1
Shortening the infusion time of anticancer drugs: who will benefit?
J Clin Oncol. 2007 Jul 1;25(19):2642-3. doi: 10.1200/JCO.2007.10.7334.
4
[Bevacizumab].
Rev Infirm. 2009 Jan-Feb(147):46-8.
6
Do oncologists believe new cancer drugs offer good value?
Oncologist. 2006 Feb;11(2):90-5. doi: 10.1634/theoncologist.11-2-90.
8
[Antibody therapy in hematology and oncology - part 1].
Med Klin (Munich). 2008 Dec 15;103(12):843-59. doi: 10.1007/s00063-008-1133-9.
10
Acral dysesthesia and trastuzumab (Herceptin).
Australas J Dermatol. 2004 Aug;45(3):195-6. doi: 10.1111/j.1440-0960.2004.00091.x.

引用本文的文献

1
Cerebrovascular events after bevacizumab treatment: an early and severe complication.
Neurocrit Care. 2011 Dec;15(3):421-7. doi: 10.1007/s12028-011-9552-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验